Author: healthadmin

A new international study challenges long-held assumptions about why elite sprinters are so fast. The findings provide a new perspective that could reshape the way Australia discovers and develops the next generation of speed athletes. Published in sports medicine,This study focuses on sprints through a dynamic systems approach. Rather than pointing to one ideal running technique, this paper argues that speed is increased through the interaction of an athlete’s body, environment, and training background. Why different sprinters move differently The research was led by Flinders University in collaboration with researchers from ALTIS, Johannes Gutenberg University and Nord University. This shows…

How many doctors are using AI tools in their practice? That’s a question we all want answered, but it’s impossible to pinpoint. But recent data may provide clues. Wolters Kluwer, which develops evidence-based clinical decision support tools for physicians, surveyed more than 500 healthcare professionals and found that 40% have encountered fraudulent AI tools at work, and 17% have used them. However, a blanket ban is not necessarily the best approach. A report on the findings calls the misuse of AI tools “shadow AI.” To explain what organizations can do to protect themselves, their providers, and their patients, senior writer…

U.S. Olympic gold medal-winning athlete Lindsey Vonn is teaming up again with infectious disease biopharmaceutical company Invivid for a new campaign centered around antibody-based treatments. The Antibodies for Every Body initiative is a national campaign established to educate the public about the use of antibodies to protect against disease. Invivid said in an April 7 statement that it chose Vonn because her career has been “defined by training with intention, overcoming challenges, and caring for your body from the inside out.” The campaign features the digital footprint of AntibodiesforAnyBody.com, an educational site focused on the function of antibodies. Also included…

A randomized trial conducted by the Oncology Clinical Trials Alliance with support from the National Cancer Institute found that duloxetine, a drug commonly used to treat chronic pain and mental illness, did not prevent nerve damage caused by chemotherapy in colorectal cancer patients. The primary analysis of Alliance A221805 is JCO Advances in Oncology. Oxaliplatin is a standard chemotherapy drug used to treat colorectal cancer, but it can often cause peripheral neuropathy and can have permanent side effects that cause numbness, tingling, and pain in the hands and feet. Duloxetine is often prescribed for chronic painful conditions such as osteoarthritis…

A more powerful flu shot may do more than prevent infection. New research suggests it may slightly lower the risk of Alzheimer’s disease, especially in older women, providing new insights into brain health and prevention. Study: Risk of Alzheimer’s dementia after high-dose versus standard-dose influenza vaccination. Image credit: Galina Sharapova/Shutterstock.com Dementia affects approximately 57 million people worldwide and is an incurable disease, highlighting the need for low-cost prevention strategies. In recent research, Neurology sought to determine whether high-dose influenza vaccines are associated with a reduced risk of Alzheimer’s disease compared with standard-dose vaccines and to identify gender-dependent differences in efficacy.…

Explore the profound threats of climate change and pollution to human health, from rising heat-related deaths to expanded diseases, and discover sustainable urban planning solutions for resilience.

A large, long-term study led by researchers at Cedars-Sinai University of Health Sciences suggests that some drugs commonly prescribed to treat irritable bowel syndrome (IBS), including antidepressants, may be associated with a small but measurable increased risk of death. Survey resultswas published in communication medicineis based on nearly 20 years of electronic health records of more than 650,000 U.S. adults with IBS, making it the largest real-world study to examine the long-term safety of IBS treatments. IBS is a chronic gastrointestinal disease that affects approximately 10% of the U.S. population. There is no cure, but dietary modifications, behavioral therapy, and…

New single-cell technology gives scientists the clearest view yet of immune cell behavior, capturing not only their genetic intent but also their real-time activity. Simultaneous RNA and protein measurements reveal cytokine activity more precisely and strengthen the basis for understanding cancer, inflammation, and treatment resistance. Published in the April 8th issue scientific reportthis discovery could ultimately sharpen the design of immunotherapy and improve prediction of patient response. Researchers at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, in collaboration with collaborators at the University of California, San Francisco and the Helen Diller Family…

Insmed’s Brin supplement has failed for the second time in four months in a mid-term trial aimed at expanding its use to new indications. New Jersey Biotechnology, Inc. has revealed that a Phase 2B study of Brin supplement in adults with moderate to severe hidradenitis suppurativa (HS) failed to meet its primary or secondary endpoints in either the 10 mg or 40 mg once-daily groups. Due to this result, the company will terminate the program. The debacle comes after Insmed reported the failure of another Brin supplement trial testing a first-in-class dipeptidyl peptidase 1 (DPP1) inhibitor in patients with chronic…

New research published in developmental science This suggests that the act of giving to others, even at a very young age, is inherently rewarding for humans. Scientists have found that young children express more happiness when they share a snack with someone else than when they receive a treat themselves. This provides evidence that human cooperation is driven by natural emotional rewards from prosocial behavior, which refers to actions aimed at benefiting others. Across many different cultures, people routinely share their resources with friends and strangers. These acts of generosity often come at a personal cost, from providing food to…